TTF (Tumor Treating Fields), Optune® involve positioning electrodes directly on the patient’s skull. Electrical fields are directed to the brain tumor. In this way, the electric fields do not damage healthy cells but definitely disrupt the process of cancerous cells dividing and multiplying, and eventually brings about the eradication of cancerous cells. This treatment has been proven to hold a clear advantage when patients are simultaneously treated with electrodes and chemotherapy.
The Optune® device constitutes a breakthrough option in this field, developed by an Israeli company Novocure®.
